Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(40%)
Terminated
1(20%)

Phase Distribution

Ph phase_4
3
60%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(1)
Other(2)

Detailed Status

Recruiting2
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 43 (75.0%)

Trials by Status

recruiting240%
terminated120%
unknown240%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_4

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702
recruitingphase_4

The Switching Antiplatelet-9 (SWAP-9) Study

NCT06588595
terminatedphase_4

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation

NCT02494284
unknownphase_3

Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis

NCT02689037
unknown

Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting

NCT01449617

Clinical Trials (5)

Showing 5 of 5 trials
NCT05681702Phase 4

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Recruiting
NCT06588595Phase 4

The Switching Antiplatelet-9 (SWAP-9) Study

Recruiting
NCT02494284Phase 4

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation

Terminated
NCT02689037Phase 3

Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis

Unknown
NCT01449617

Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5